Myeloperoxidase Genotypes and Enhanced Efficacy of Chemotherapy for Early-Stage Breast Cancer in SWOG-8897

PURPOSE: Myeloperoxidase (MPO) generates reactive oxygen species and also activates xenobiotics. In a rigorous clinical trial (Southwest Oncology Group SWOG-8897), we examined relationships between genotypes and disease-free survival (DFS) among women treated for breast cancer, as well as those who...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ambrosone, Christine B., Barlow, William E., Reynolds, Wanda, Livingston, Robert B., Yeh, I-Tien, Choi, Ji-Yeob, Davis, Warren, Rae, James M., Tang, Li, Hutchins, Laura R., Ravdin, Peter M., Martino, Silvana, Osborne, C. Kent, Lyss, Alan P., Hayes, Daniel F., Albain, Kathy S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2009
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2799053/
https://ncbi.nlm.nih.gov/pubmed/19752340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.8669
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak